STOCK TITAN

Rani Therapeutics Holdings (RANI) Stock News, Apr-Aug 2023

RANI NASDAQ

Rani Therapeutics Holdings, Inc. reports developments tied to its clinical-stage biotherapeutics platform for oral delivery of biologics and drugs. The company’s RaniPill® capsule technology is designed to deliver drug substances such as antibodies, proteins, peptides and oligonucleotides as an alternative to subcutaneous injection or intravenous infusion.

Recurring RANI news includes clinical and preclinical updates for RaniPill-based programs, including RT-114, a GLP-1/GLP-2 dual agonist program for obesity, and oral semaglutide work. Company updates also cover financial results, collaboration and license activity, private placement financing, manufacturing and supply-chain capabilities, pipeline prioritization, investor conference participation, and leadership or advisory appointments supporting platform and clinical strategy.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.52%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.18%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.47%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.56%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.35%
Tags
partnership
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.90%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.84%
Tags
Rhea-AI Summary

Rani Therapeutics, a clinical-stage biotherapeutics company, announced that its CEO, Talat Imran, will participate in a fireside chat at the H.C. Wainwright BioConnect Investor Conference on May 2, 2023, at 11:30 AM ET. The event will showcase Rani's innovative approach to oral delivery of biologics and drugs, primarily through its patented RaniPill® capsule technology, which aims to replace traditional injection methods. Interested parties can access the live webcast from the Investor Relations section of Rani Therapeutics' website, with a replay available post-event.

Rani Therapeutics is dedicated to enhancing drug delivery systems and has successfully conducted multiple preclinical and clinical studies to validate the safety and efficacy of its oral dosing technologies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.34%
Tags
conferences

FAQ

What is the current stock price of Rani Therapeutics Holdings (RANI)?

Rani Therapeutics Holdings (RANI) last closed at $0.5111.

What is the market cap of Rani Therapeutics Holdings (RANI)?

The market cap of Rani Therapeutics Holdings (RANI) is approximately $59.0M.